Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inmaculada Hernandez
Yuting Zhang

Showing results (21-30 of 1,451) with videos related to

Pageof 146
Sort By:
The American Journal of Cardiology|May 4, 2020
Real-World Direct Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Medicare Beneficiaries With Atrial FibrillationLanting Yang, Maria M Brooks, Nancy W Glynn, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 24, 2024
Projected prescription drug expenditures in 2024: Looking ahead to the inflation reduction eraInmaculada Hernandez
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 13, 2015
Time to reconsider dabigatran 110 mg in the USAInmaculada Hernandez
JAMA Internal Medicine|August 8, 2017
Revisiting Outcomes-Based Pricing Propositions for the PCSK9 Inhibitor EvolocumabInmaculada Hernandez
Journal of Managed Care & Specialty Pharmacy|December 28, 2023
A primer on brand-name prescription drug reimbursement in the United StatesInmaculada Hernandez, Anna Hung
Journal of Managed Care & Specialty Pharmacy|February 25, 2023
Drugs likely subject to Medicare negotiation, 2026-2028Sean Dickson, Inmaculada Hernandez
JAMA Internal Medicine|June 6, 2018
Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit VaccineChester B Good, Inmaculada Hernandez
JAMA|October 18, 2022
Pharmaceutical Spending in Fee-for-Service Medicare: Looking Ahead to the Inflation Reduction ActWalid F Gellad, Inmaculada Hernandez
JAMA Health Forum|October 11, 2022
Decomposition of Expenditures for Insulins Across the Distribution Chain-Insights Into Rising Prices?Chester B Good, Inmaculada Hernandez
Obesity (Silver Spring, Md.)|January 16, 2024
Net prices of new antiobesity medicationsInmaculada Hernandez, Sean D Sullivan
Pageof 146

Showing results (21-30 of 1,451) with videos related to

Sort By:
Pageof 146
The American Journal of Cardiology|May 4, 2020
Real-World Direct Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Medicare Beneficiaries With Atrial FibrillationLanting Yang, Maria M Brooks, Nancy W Glynn, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 24, 2024
Projected prescription drug expenditures in 2024: Looking ahead to the inflation reduction eraInmaculada Hernandez
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 13, 2015
Time to reconsider dabigatran 110 mg in the USAInmaculada Hernandez
JAMA Internal Medicine|August 8, 2017
Revisiting Outcomes-Based Pricing Propositions for the PCSK9 Inhibitor EvolocumabInmaculada Hernandez
Journal of Managed Care & Specialty Pharmacy|December 28, 2023
A primer on brand-name prescription drug reimbursement in the United StatesInmaculada Hernandez, Anna Hung
Journal of Managed Care & Specialty Pharmacy|February 25, 2023
Drugs likely subject to Medicare negotiation, 2026-2028Sean Dickson, Inmaculada Hernandez
JAMA Internal Medicine|June 6, 2018
Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit VaccineChester B Good, Inmaculada Hernandez
JAMA|October 18, 2022
Pharmaceutical Spending in Fee-for-Service Medicare: Looking Ahead to the Inflation Reduction ActWalid F Gellad, Inmaculada Hernandez
JAMA Health Forum|October 11, 2022
Decomposition of Expenditures for Insulins Across the Distribution Chain-Insights Into Rising Prices?Chester B Good, Inmaculada Hernandez
Obesity (Silver Spring, Md.)|January 16, 2024
Net prices of new antiobesity medicationsInmaculada Hernandez, Sean D Sullivan
Pageof 146